Membrane transport of mitoxantrone by L1210 leukemia cells

Transport of radiolabeled mitoxantrone, a new antineoplastic agent, was studied using cultured mouse L1210 leukemia cells. The initial velocity of influx remained linear for about 90 sec and was 110 pmoles/10 6 cells measured at 60 sec. The steady-state accumulation of about 480 pmoles/10 6 cells wa...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Biochemical pharmacology 1987-03, Vol.36 (6), p.857-860
Hauptverfasser: Burns, C.Patrick, Haugstad, Bradley N., North, James A.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 860
container_issue 6
container_start_page 857
container_title Biochemical pharmacology
container_volume 36
creator Burns, C.Patrick
Haugstad, Bradley N.
North, James A.
description Transport of radiolabeled mitoxantrone, a new antineoplastic agent, was studied using cultured mouse L1210 leukemia cells. The initial velocity of influx remained linear for about 90 sec and was 110 pmoles/10 6 cells measured at 60 sec. The steady-state accumulation of about 480 pmoles/10 6 cells was not reached until 30min. The unidirectional drug influx was linear from 0 to 1000 μM extracellular drug concentration. The initial uptake was relatively temperature independent between 37° and 27°, but accumulation at steady state was 17% lower at 27°. None of six metabolic inhibitors had an appreciable effect on initial uptake. Efflux was initially exponential with a half-life of 2.8 min; this efflux and the residual drug concentration plateau were not affected by KCN or verapamil. Under steady-state conditions, about 86% of the cell-associated label was contained in parent drug and the remainder in an unidentified metabolite. These studies indicate that the mechanism of mitoxantrone uptake is passive diffusion. The efflux is not energy requiring, but there is considerable tight binding of the drug to cellular structures.
doi_str_mv 10.1016/0006-2952(87)90176-6
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_77468861</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>0006295287901766</els_id><sourcerecordid>14734991</sourcerecordid><originalsourceid>FETCH-LOGICAL-c417t-5a4e1caf5a16dbb4b9fd8fc7ae02532600364385b96634c19f5647dae409388e3</originalsourceid><addsrcrecordid>eNqFkE1LxDAQhoMoun78A4UeRPRQTZp0kngQRPyCFS96Dmk6hWi7XZOu6L83dZc96iUh8z4zTB5CDhk9Z5TBBaUU8kKXxamSZ5oyCTlskAlTkqcyqE0yWSM7ZDfGt_GpgG2TbV4CSAUTcvmEXRXsDLMhnXHehyHrm6zzQ_9lZ0PoU1J9Z1NWMJq1uHjHztvMYdvGfbLV2DbiwereI693ty83D_n0-f7x5nqaO8HkkJdWIHO2KS2DuqpEpZtaNU5apEXJC6CUg-CqrDQAF47ppgQha4uCaq4U8j1yspw7D_3HAuNgOh_HDdLW_SIaKQWo9K1_QSYkF1qPoFiCLvQxBmzMPPjOhm_DqBndmtGUGcUZJc2vWwOp7Wg1f1F1WK-bVjJTfrzKbXS2bZJQ5-Mak0KzkouEXS0xTNI-PQYTnceZw9oHdIOpe__3Hj9jvZMg</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>14734991</pqid></control><display><type>article</type><title>Membrane transport of mitoxantrone by L1210 leukemia cells</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals Complete</source><creator>Burns, C.Patrick ; Haugstad, Bradley N. ; North, James A.</creator><creatorcontrib>Burns, C.Patrick ; Haugstad, Bradley N. ; North, James A.</creatorcontrib><description>Transport of radiolabeled mitoxantrone, a new antineoplastic agent, was studied using cultured mouse L1210 leukemia cells. The initial velocity of influx remained linear for about 90 sec and was 110 pmoles/10 6 cells measured at 60 sec. The steady-state accumulation of about 480 pmoles/10 6 cells was not reached until 30min. The unidirectional drug influx was linear from 0 to 1000 μM extracellular drug concentration. The initial uptake was relatively temperature independent between 37° and 27°, but accumulation at steady state was 17% lower at 27°. None of six metabolic inhibitors had an appreciable effect on initial uptake. Efflux was initially exponential with a half-life of 2.8 min; this efflux and the residual drug concentration plateau were not affected by KCN or verapamil. Under steady-state conditions, about 86% of the cell-associated label was contained in parent drug and the remainder in an unidentified metabolite. These studies indicate that the mechanism of mitoxantrone uptake is passive diffusion. The efflux is not energy requiring, but there is considerable tight binding of the drug to cellular structures.</description><identifier>ISSN: 0006-2952</identifier><identifier>EISSN: 1873-2968</identifier><identifier>DOI: 10.1016/0006-2952(87)90176-6</identifier><identifier>PMID: 3566786</identifier><identifier>CODEN: BCPCA6</identifier><language>eng</language><publisher>New York, NY: Elsevier Inc</publisher><subject>Animals ; Antineoplastic agents ; antineoplastic drugs ; Biological and medical sciences ; Biological Transport ; Cell Membrane - metabolism ; Cells, Cultured ; General aspects ; Half-Life ; Kinetics ; leukemia ; Leukemia L1210 - metabolism ; Medical sciences ; Mice ; mitoxantrone ; Mitoxantrone - metabolism ; Pharmacology. Drug treatments ; Temperature</subject><ispartof>Biochemical pharmacology, 1987-03, Vol.36 (6), p.857-860</ispartof><rights>1987</rights><rights>1988 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c417t-5a4e1caf5a16dbb4b9fd8fc7ae02532600364385b96634c19f5647dae409388e3</citedby><cites>FETCH-LOGICAL-c417t-5a4e1caf5a16dbb4b9fd8fc7ae02532600364385b96634c19f5647dae409388e3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/0006-2952(87)90176-6$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,777,781,3537,27905,27906,45976</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=7491534$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/3566786$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Burns, C.Patrick</creatorcontrib><creatorcontrib>Haugstad, Bradley N.</creatorcontrib><creatorcontrib>North, James A.</creatorcontrib><title>Membrane transport of mitoxantrone by L1210 leukemia cells</title><title>Biochemical pharmacology</title><addtitle>Biochem Pharmacol</addtitle><description>Transport of radiolabeled mitoxantrone, a new antineoplastic agent, was studied using cultured mouse L1210 leukemia cells. The initial velocity of influx remained linear for about 90 sec and was 110 pmoles/10 6 cells measured at 60 sec. The steady-state accumulation of about 480 pmoles/10 6 cells was not reached until 30min. The unidirectional drug influx was linear from 0 to 1000 μM extracellular drug concentration. The initial uptake was relatively temperature independent between 37° and 27°, but accumulation at steady state was 17% lower at 27°. None of six metabolic inhibitors had an appreciable effect on initial uptake. Efflux was initially exponential with a half-life of 2.8 min; this efflux and the residual drug concentration plateau were not affected by KCN or verapamil. Under steady-state conditions, about 86% of the cell-associated label was contained in parent drug and the remainder in an unidentified metabolite. These studies indicate that the mechanism of mitoxantrone uptake is passive diffusion. The efflux is not energy requiring, but there is considerable tight binding of the drug to cellular structures.</description><subject>Animals</subject><subject>Antineoplastic agents</subject><subject>antineoplastic drugs</subject><subject>Biological and medical sciences</subject><subject>Biological Transport</subject><subject>Cell Membrane - metabolism</subject><subject>Cells, Cultured</subject><subject>General aspects</subject><subject>Half-Life</subject><subject>Kinetics</subject><subject>leukemia</subject><subject>Leukemia L1210 - metabolism</subject><subject>Medical sciences</subject><subject>Mice</subject><subject>mitoxantrone</subject><subject>Mitoxantrone - metabolism</subject><subject>Pharmacology. Drug treatments</subject><subject>Temperature</subject><issn>0006-2952</issn><issn>1873-2968</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1987</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkE1LxDAQhoMoun78A4UeRPRQTZp0kngQRPyCFS96Dmk6hWi7XZOu6L83dZc96iUh8z4zTB5CDhk9Z5TBBaUU8kKXxamSZ5oyCTlskAlTkqcyqE0yWSM7ZDfGt_GpgG2TbV4CSAUTcvmEXRXsDLMhnXHehyHrm6zzQ_9lZ0PoU1J9Z1NWMJq1uHjHztvMYdvGfbLV2DbiwereI693ty83D_n0-f7x5nqaO8HkkJdWIHO2KS2DuqpEpZtaNU5apEXJC6CUg-CqrDQAF47ppgQha4uCaq4U8j1yspw7D_3HAuNgOh_HDdLW_SIaKQWo9K1_QSYkF1qPoFiCLvQxBmzMPPjOhm_DqBndmtGUGcUZJc2vWwOp7Wg1f1F1WK-bVjJTfrzKbXS2bZJQ5-Mak0KzkouEXS0xTNI-PQYTnceZw9oHdIOpe__3Hj9jvZMg</recordid><startdate>19870315</startdate><enddate>19870315</enddate><creator>Burns, C.Patrick</creator><creator>Haugstad, Bradley N.</creator><creator>North, James A.</creator><general>Elsevier Inc</general><general>Elsevier Science</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>8FD</scope><scope>FR3</scope><scope>M7Z</scope><scope>P64</scope><scope>7X8</scope></search><sort><creationdate>19870315</creationdate><title>Membrane transport of mitoxantrone by L1210 leukemia cells</title><author>Burns, C.Patrick ; Haugstad, Bradley N. ; North, James A.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c417t-5a4e1caf5a16dbb4b9fd8fc7ae02532600364385b96634c19f5647dae409388e3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1987</creationdate><topic>Animals</topic><topic>Antineoplastic agents</topic><topic>antineoplastic drugs</topic><topic>Biological and medical sciences</topic><topic>Biological Transport</topic><topic>Cell Membrane - metabolism</topic><topic>Cells, Cultured</topic><topic>General aspects</topic><topic>Half-Life</topic><topic>Kinetics</topic><topic>leukemia</topic><topic>Leukemia L1210 - metabolism</topic><topic>Medical sciences</topic><topic>Mice</topic><topic>mitoxantrone</topic><topic>Mitoxantrone - metabolism</topic><topic>Pharmacology. Drug treatments</topic><topic>Temperature</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Burns, C.Patrick</creatorcontrib><creatorcontrib>Haugstad, Bradley N.</creatorcontrib><creatorcontrib>North, James A.</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Technology Research Database</collection><collection>Engineering Research Database</collection><collection>Biochemistry Abstracts 1</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>Biochemical pharmacology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Burns, C.Patrick</au><au>Haugstad, Bradley N.</au><au>North, James A.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Membrane transport of mitoxantrone by L1210 leukemia cells</atitle><jtitle>Biochemical pharmacology</jtitle><addtitle>Biochem Pharmacol</addtitle><date>1987-03-15</date><risdate>1987</risdate><volume>36</volume><issue>6</issue><spage>857</spage><epage>860</epage><pages>857-860</pages><issn>0006-2952</issn><eissn>1873-2968</eissn><coden>BCPCA6</coden><abstract>Transport of radiolabeled mitoxantrone, a new antineoplastic agent, was studied using cultured mouse L1210 leukemia cells. The initial velocity of influx remained linear for about 90 sec and was 110 pmoles/10 6 cells measured at 60 sec. The steady-state accumulation of about 480 pmoles/10 6 cells was not reached until 30min. The unidirectional drug influx was linear from 0 to 1000 μM extracellular drug concentration. The initial uptake was relatively temperature independent between 37° and 27°, but accumulation at steady state was 17% lower at 27°. None of six metabolic inhibitors had an appreciable effect on initial uptake. Efflux was initially exponential with a half-life of 2.8 min; this efflux and the residual drug concentration plateau were not affected by KCN or verapamil. Under steady-state conditions, about 86% of the cell-associated label was contained in parent drug and the remainder in an unidentified metabolite. These studies indicate that the mechanism of mitoxantrone uptake is passive diffusion. The efflux is not energy requiring, but there is considerable tight binding of the drug to cellular structures.</abstract><cop>New York, NY</cop><pub>Elsevier Inc</pub><pmid>3566786</pmid><doi>10.1016/0006-2952(87)90176-6</doi><tpages>4</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0006-2952
ispartof Biochemical pharmacology, 1987-03, Vol.36 (6), p.857-860
issn 0006-2952
1873-2968
language eng
recordid cdi_proquest_miscellaneous_77468861
source MEDLINE; Elsevier ScienceDirect Journals Complete
subjects Animals
Antineoplastic agents
antineoplastic drugs
Biological and medical sciences
Biological Transport
Cell Membrane - metabolism
Cells, Cultured
General aspects
Half-Life
Kinetics
leukemia
Leukemia L1210 - metabolism
Medical sciences
Mice
mitoxantrone
Mitoxantrone - metabolism
Pharmacology. Drug treatments
Temperature
title Membrane transport of mitoxantrone by L1210 leukemia cells
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-17T14%3A18%3A21IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Membrane%20transport%20of%20mitoxantrone%20by%20L1210%20leukemia%20cells&rft.jtitle=Biochemical%20pharmacology&rft.au=Burns,%20C.Patrick&rft.date=1987-03-15&rft.volume=36&rft.issue=6&rft.spage=857&rft.epage=860&rft.pages=857-860&rft.issn=0006-2952&rft.eissn=1873-2968&rft.coden=BCPCA6&rft_id=info:doi/10.1016/0006-2952(87)90176-6&rft_dat=%3Cproquest_cross%3E14734991%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=14734991&rft_id=info:pmid/3566786&rft_els_id=0006295287901766&rfr_iscdi=true